Using synbiotics to reduce the risk of preterm birth
Official title: Synbiotics in Patients at RIsk fOr Preterm Birth: a Multi-center Double-blind Randomized Placebo-controlled trIal
Run by Ziekenhuis Oost-Limburg · NCT05966649 · Data updated 2026-11-12
This study is testing if taking synbiotics can help women at high risk for preterm birth have healthier pregnancies by improving their vaginal microbiome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 402 (estimated) |
| Sponsor | Ziekenhuis Oost-Limburg Academic / other |
| Locations | 9 sites (Edegem, Antwerpen and 8 other locations) |
| Status | Recruiting |
| Started | March 16, 2023 |
| Main results expected | December 2028 |
| Study ends | June 2029 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT05966649 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older with a singleton pregnancy who have a history of preterm birth or other risk factors for spontaneous preterm labor.
✕Probably not a fit
Patients with multiple pregnancies or those currently using pro-, pre-, or synbiotics may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of synbiotics in women at high risk for preterm birth, particularly those with a history of spontaneous preterm delivery or other related complications. The study aims to assess whether synbiotics can positively influence the vaginal microbiome and potentially reduce the incidence of preterm labor. Participants will be randomly assigned to receive either synbiotics or a placebo, and their outcomes will be monitored throughout the pregnancy. The trial seeks to provide insights into the relationship between microbial colonization and preterm birth.
Why it matters
Potential benefit: If successful, this study could lead to new preventive strategies for reducing the risk of preterm birth in high-risk women.
How similar studies have gone: While the use of synbiotics in pregnancy is an emerging area, previous studies have shown promising results in related fields, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Signed written informed consent must be obtained before any study assessment is performed; 2. 18 years of age or older; 3. Singleton pregnancy; 4. Pregnancy consultation between 8 and 10 weeks gestation. 5. At least one of the following risk factors for spontaneous preterm birth: * Prior spontaneous preterm birth, defined as delivery between 24 and 36 weeks following PPROM, preterm labor or cervical insufficiency * PPROM ≤36 weeks in previous pregnancy * Prior spontaneous second-trimester pregnancy loss, defined as PPROM, preterm labor or cervical insufficiency with birth between 14 and 24 weeks. Exclusion Criteria: 1. Patients who are already using pro-, pre- or synbiotics and not willing to stop 2. Multiple pregnancy 3. Need for primary (type 1) cerclage 4. Inflammatory bowel disease 5. Known congenital uterine anomaly 6. History of LLETZ conization
Where it's running
-
Universitaire Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium Recruiting -
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium Recruiting -
Universitaire Ziekenhuizen Leuven
Leuven, Limburg, Belgium Recruiting -
CHR Citadelle
Liège, Liège, Belgium Recruiting -
UZ Gent
Ghent, Oost-Vlaanderen, Belgium Recruiting -
AZ Sint-Jan
Bruges, West-Vlaanderen, Belgium Recruiting
Show 3 more locations
-
AZ Sint-Lucas
Bruges, West-Vlaanderen, Belgium Recruiting -
AZ Maria Middelares
Ghent, West-Vlaanderen, Belgium Recruiting -
AZ Groeninge
Kortrijk, Belgium Recruiting
Study contacts
- Study coordinator: Caroline Van Holsbeke, PhD
- Email: Caroline.van.holsbeke@zol.be
- Phone: 003289804057
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Cervical stiffness test to help predict preterm birth in at-risk pregnant women
A simple cervical stiffness test using the Pregnolia device is being studied to see if it can better identify women with threatened preterm labor who are likely to give birth soon.
-
LpD3.5 Intervention for Gut Health and Cognition in Older Adults with MCI
In older adults with mild cognitive impairment, this study tests whether daily LpD3.5 capsules can improve gut health and potentially cognition compared with placebo.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
How doctors and nurses decide about bed rest in pregnancy
This study tests a plan to stop routinely restricting activity or bed rest during pregnancy to see if providers accept it, find it appropriate, and change how often they recommend it for women at risk of preterm birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.